Shortage of key drug hampering U.S. efforts to control TB, report says

Shortage of key drug hampering U.S. efforts to control TB: report
Many health departments have altered treatment practices; CDC officials working to solve the problem.

(HealthDay)—A shortage of a critical tuberculosis drug has hampered the efforts of health departments across the United States to contain the spread of the highly infectious lung disease, federal officials report.

The drug, isoniazid (INH), was first used in 1951 and is one of four drugs considered to be the core of any first-line treatment for tuberculosis (TB). Patients must take the drugs for six to nine months, according to the U.S. .

However, a of local health departments around the country in January found that many health departments and clinics were having trouble getting INH. According to the report, published in the May 24 issue of the CDC publication, Morbidity and Mortality Weekly Report, the shortage first became severe in November 2012 and was attributed to manufacturing and supply problems.

The January survey, conducted by the National Tuberculosis Controllers Association online, was sent to 68 jurisdictions in all 50 states, including health departments in 10 large U.S. cities.

The survey found that 79 percent of the TB programs that responded said they were having difficulty obtaining INH, 41 percent said they would run out of the drug within a month and 15 percent no longer had any of the drug left.

To deal with the shortage, 69 percent of the TB programs said they switched suppliers, 72 percent prioritized high-, 68 percent delayed treatment and 88 percent tried alternative treatments. Forty-four percent said they switched to more expensive TB .

The CDC researchers said that while the shortage of INH is easing, many health departments still can't get supplies of the drug and have changed their treatment practices to deal with the shortage. The CDC is working with local, state and international officials, along with suppliers of INH, to alleviate the shortage.

More information: For more on tuberculosis, go to the U.S. Centers for Disease Control and Prevention.

add to favorites email to friend print save as pdf

Related Stories

US urges shorter treatment for TB

Dec 08, 2011

US health authorities on Thursday urged a 12-week drug regimen for people with latent tuberculosis as an effective alternative to the current nine-month regimen which many people do not finish.

Tuberculosis in US hits record low

Mar 21, 2013

Cases of tuberculosis reached an all-time low in the United States last year, but the disease continued to affect minorities at much higher rates than whites, health authorities said Thursday.

Study finds vitamin C can kill drug-resistant TB (w/ video)

May 21, 2013

In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding ...

Recommended for you

Two US states order tough Ebola quarantine rules

5 hours ago

New York and New Jersey on Friday ordered a mandatory quarantine for medics who treated victims of Ebola in West Africa, after the deadly virus spread to America's largest city.

NY and NJ say they will require Ebola quarantines

23 hours ago

The governors of New Jersey and New York on Friday ordered a mandatory, 21-day quarantine for all doctors and other arriving travelers who have had contact with Ebola victims in West Africa.

User comments